Cocktail Event – June 28, 2017

Liberty Silver

Liberty Silver Corp. is focused on exploring and developing mineral properties located in North America. The Company is led by an experienced, management team and board of directors with significant experience managing exploration, development and mining projects. Liberty has the right to earn a joint venture interest in the 10,020-acre Trinity Silver Project. The Trinity Silver Project, located in Pershing County, Nevada, is Liberty’s flagship project. Liberty recently announced that it has entered into the Letter of Intent to Acquire the Bunker Hill Mine Complex which is subject to due diligence and definitive documentation. CSE:LSL (Recent SP: $1.50)

Liberty Silver – Bunker Hill Presentation June 2017

Xebec

Xebec is a gas generation, purification and filtration company that develops, designs and manufactures gas purification products and technology solutions for environmentally responsible applications in industry, transportation and the public sector. On May 24th, 2017 the company reported Q1 2017 revenues of $3.3M, gross profit of $1.4M and a positive EBITDA of $0.7M. Xebec currently has more than 9,000 units deployed worldwide to over 1,500 clients.  TSX.V: XBC (Recent SP: $0.39)

Xebec Presentation June 2017

RMCGroup RMC Corporation (RMC) invests in, sponsors, and is the General Partner in underappreciated income producing office properties in secondary US markets. It currently oversees approximately 9M SF, representing over $1bn in asset value, principally in the Midwest. RMC’s principals seek long-term co-investment partners, not ‘clients,’ as such, RMC only levies its charges up-front and only in the form of shares in the partnership. It does not charge ‘back end,’ ‘carry,’ or even management fees that hemorrhage returns on partners’ capital – a structure that is unique in both its low pricing and risk sharing. RMC has offices in Montreal, London & New York City. 

Group RMC Presentation June 2017

PreveCeutical

PreveCeutical is a health and wellness company focused on utilizing nature and science for the benefit of health conscious consumers. PreveCeutical’s lead product is the CellB9 supplement, which harnesses the effects of scorpion venom. The company is in the process of developing a pharmaceutical treatment around the venom to validate its health benefits. In addition, PreveCeutical is working on a cannabinoid delivery agent known as Sol-Gels, as well as conducting research on gene therapy treatments. PreveCeutical is currently involved in a RTO with Carrara Exploration. CSE: CAA (Recent SP: $0.22)

PreveCeutical Presentation – June 2017